Señales en vivo de DRRX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Stats
Volumen de hoy	103 811
Volumen promedio	158 183
Capitalización de mercado	37.24M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $-0.210 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.000
ATR14	$0.0120 (1.01%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-21	Robertson Judith J.	Buy	5 500	Stock Option (right to buy)
2023-06-21	Maderis Gail J	Buy	5 500	Stock Option (right to buy)
2023-06-21	Garcia Peter S	Buy	5 500	Stock Option (right to buy)
2023-06-21	Farfel Gail M	Buy	5 500	Stock Option (right to buy)
2023-06-21	Blaschke Terrence F	Buy	5 500	Stock Option (right to buy)

INSIDER POWER
99.12
Last 97 transactions
Buy: 5 988 954 \| Sell: 1 498 606

Volumen Correlación

Largo: 0.25 (neutral)

Corto: -0.09 (neutral)

Signal:(47.341) Neutral

DURECT Corp Correlación

10 Correlaciones Más Positivas
APOP	0.917
RMRM	0.903
KNSL	0.895
GAINL	0.885
MRSN	0.884
DDI	0.882
EDRY	0.881
TW	0.878
KYMR	0.877
KTRA	0.87

10 Correlaciones Más Negativas
BOCH	-0.926
SRNGW	-0.896
DSPC	-0.88
GSM	-0.878
MMAC	-0.878
SVOK	-0.873
RTPY	-0.863
RELL	-0.859
VIH	-0.859
TCFC	-0.858

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DURECT Corp Correlación - Moneda/Commodity

0.28
( neutral )

-0.01
( neutral )

0.00
( neutral )

0.28
( neutral )

0.45
( neutral )

-0.17
( neutral )

DURECT Corp Finanzas

Annual	2023
Ingresos:	$8.55M
Beneficio Bruto:	$6.83M (79.91 %)
EPS:	$-1.050

FY	2023
Ingresos:	$8.55M
Beneficio Bruto:	$6.83M (79.91 %)
EPS:	$-1.050

FY	2022
Ingresos:	$19.28M
Beneficio Bruto:	$17.70M (91.76 %)
EPS:	$-1.560

FY	2021
Ingresos:	$13.98M
Beneficio Bruto:	$12.02M (86.01 %)
EPS:	$-0.0161

Financial Reports:

No articles found.

DURECT Corp

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.